Business Context and Reporting Period
This Form 8-K Current Report was filed by Intuitive Surgical, Inc. on May 28, 2026. The filing reports a material change in executive leadership effective July 1, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statement data.
Material Changes
- Executive Transition: Henry L. Charlton will transition from Chief Commercial and Marketing Officer to Senior Vice President of Global Business Operations.
- Appointment: Taylor Patton, currently Global Senior Vice President, Endoluminal, will succeed Mr. Charlton as Chief Commercial and Marketing Officer.
- Effective Date: These changes are effective July 1, 2026.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on future performance, risks, contingencies, or unusual items. The document references a press release (Exhibit 99.1) for further details but does not include its content.
Investor Verification Checklist
- Verify the strategic rationale for the leadership change by reviewing the press release attached as Exhibit 99.1.
- Confirm the specific responsibilities of the new Chief Commercial and Marketing Officer, Taylor Patton.
- Monitor subsequent filings for any impact of this transition on commercial strategy or operational execution.